How has been the historical performance of Ajooni Biotech?

Answer:The historical performance of Ajooni Biotech shows significant growth in net sales and profit over the years, with the latest figures for March 2025 indicating a net sales of 114.69 crore and a profit after tax of 3.37 crore. Breakdown: Ajooni Biotech has demonstrated a consistent upward trend in net sales, increasing from 39.72 crore in March 2019 to 114.69 crore in March 2025. This growth is accompanied by a rise in total operating income, which reached 114.69 crore in March 2025, up from 40.06 crore in March 2019. The company's total expenditure also rose significantly, from 39.17 crore in March 2019 to 111.01 crore in March 2025, reflecting increased operational costs. Operating profit, excluding other income, improved from 0.89 crore in March 2019 to 3.68 crore in March 2025, while profit before tax rose from 0.47 crore to 4.33 crore in the same period. The profit after tax saw a notable increase from 0.41 crore in March 2019 to 3.37 crore in March 2025. On the balance sheet, total assets grew from 22.94 crore in March 2019 to 94.67 crore in March 2025, with total liabilities also increasing from 22.94 crore to 94.67 crore. The cash flow from operating activities has fluctuated, showing a negative cash flow of 17 crore in March 2025, contrasting with a positive cash flow of 22 crore in March 2024. Overall, Ajooni Biotech's financial performance reflects substantial growth in sales and profitability over the years, despite some volatility in cash flow.